肝硬化套扎联合硬化序贯治疗的疗效评价

Abstract
Figure/Table
References
Related Citation (4)

Download: PDF (581 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the efficacy of esophageal vein ligation combined with endoscopic injection sclerotherapy sequential treatment of esophageal variceal bleeding in cirrhosis.Methods Fifty-seven patients with cirrhosis and esophageal variceal bleeding after twice esophageal variceal ligation, whose endoscopic grade of esophageal varices was still moderate (G₂) and severe (G₃), were selected between April 2014 and April 2017 as the subjects.Using the random number table method, these patients were divided into the control group of 28 cases and the study group of 29 cases. The study group was treated with EIS sequential therapy,while the control group continued to be treated with EVL sequential therapy. Both groups were followed up for one year after treatment and results of gastroscopy were reviewed. The number of times of sequential treatment、rate esophageal varice eradication, incidence of rebleeding, and incidence of complications were compared between the two groups.Results Sequential treatment was less frequent in the study group (2.24±0.95) than in the control group (3.29 ±1.27). The rate of esophageal varice eradication was(89.66%) in the study group, which was significantly better than that of the control group(46.43%), and the rate of rebleeding(2.45%) was lower than that of the control group (P<0.05). There was no statistically significant difference in the incidence of complications between the two groups (P>0.05).Conclusions EVL and EIS sequential therapy in the treatment of cirrhosis with esophageal variceal bleeding can effectively reduce the frequency of endoscopic treatment, mitigate residual esophageal varices after ligation, delay the recurrence of varicose veins, and without any increased risk of complications.

Key words： esophageal vein ligation endoscopic injection sclerotherapy cirrhosis esophageal varices

Received: 08 August 2018

ZTFLH:

R657.31

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2018/V29/I12/1138

[1]	中华医学会肝病学分会,中华医学会消化病学分会,中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治共识[J].临床肝病杂志,2016,32(2):203-219.
[2]	Cerini F, Gonzalez J M, Torres F, et al. Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study[J]. Hepatology, 2015, 62(2):575-583.
[3]	胥雄阳, 张仕泽, 杨兴平,等.套扎术联合硬化术治疗食管胃底静脉曲张破裂出血的疗效观察[J].西部医学,2014,26(12):1662-1663.
[4]	晋琼玉,徐泽艳,徐静,等.内镜下套扎联合硬化术及药物治疗食管胃底静脉曲张出血的临床疗效观察[J]. 西部医学, 2013, 25(9):1365-1367.
[5]	顾星石, 白旭明, 程龙,等.经颈静脉肝内门体静脉分流术治疗肝硬化上消化道出血的中远期疗效观察[J].内科理论与实践,2015,10(4):266-271.
[6]	中华医学会消化内镜学分会食管胃静脉曲张组.消化道静脉曲张及出血的内镜诊断和治疗规范试行方案(2009年)[J].中华消化内镜杂志,2010,27(1) :1-4.
[7]	叶营, 孙相钊, 蔡春调,等.内镜联合药物诊治肝硬化食管胃底静脉曲张破裂出血的疗效及再出血危险因素研究[J].海南医学, 2017, 28(3):374-378.
[8]	Marmo R, Piano M D, Cipolletta L, et al. 1039 Mortality From Non Variceal Upper Gastrointestinal Bleeding in Patients With Liver Cirrhosis: an Individual Patient Data Meta-Analysis[J]. Gastrointestinal Endoscopy, 2013, 77(5):AB180-AB180.
[9]	司淑平,占强,王辉,等.内镜下聚桂醇注射液硬化治疗食管静脉曲张破裂出血的效果观察[J].中国内镜杂志,2016,22(6):1-4.
[10]	高成广, 谢峰, 冯亚东.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的效果观察[J].临床肝胆病杂志,2016, 32(2):284-287.
[11]	曹世堂,黄敏捷,刘克祥,等.酚磺乙胺联合奥曲肽治疗肝硬化上消化道出血的临床研究[J]. 现代药物与临床,2017, 32(9):1679-1682.
[12]	张晖,进军,左凡,等.内镜下食管静脉曲张套扎术治疗肝硬化食管静脉曲张56例疗效观察[J].山东医药, 2015,55(2):63-65.
[13]	庞美志,何咖鲒.内镜下套扎术联合硬化剂注射术治疗食管静脉曲张破裂出血的疗效观察[J].广西医学,2014,36(7):983-985.
[14]	忻笑容,陈平,朱时燕,等.内镜下静脉曲张套扎术对肝硬化患者主要器官功能影响临床分析[J].肝脏,2017,22(10):907-911.
[15]	朱松平,黄泽夏.内镜下曲张静脉套扎术治疗肝硬化食管静脉曲张患者临床分析[J].中国医师进修杂志,2013,36(28):54-55.